Fannie Mae Reports Net Income of $17.0 Billion for 2024 and $4.1 Billion for Fourth Quarter 2024
- 41
PR Newswire
WASHINGTON, Feb. 14, 2025
WASHINGTON, Feb. 14, 2025 /PRNewswire/ -- Fannie Mae (OTCQB: FNMA) today reported its fourth quarter and full-year 2024 financial results and filed its 2024 Form 10-K with the Securities and Exchange Commission. The filing provides consolidated financial statements for the year ended December 31, 2024. The following documents are now available on Fannie Mae's website at www.fanniemae.com.
- Press release announcing fourth quarter and full-year 2024 financial results
- Fannie Mae's Form 10-K for the year ended December 31, 2024
- Q4 and Full-Year 2024 Financial Supplement
Fannie Mae has scheduled a conference call to discuss the company's results today at 8:00 a.m., ET. Participants may join the conference call in listen-only mode via the webcast link below.
Listen-only webcast:
https://event.webcasts.com/starthere.jsp?ei=1704775&tp_key=159ba11bd8
Click on the link above to attend the presentation from your laptop, tablet, or mobile device. Audio will stream through your selected device. If you have difficulty accessing the webcast, please click the "Listen by Phone" button on the webcast player and dial the number provided.
About Fannie Mae
Fannie Mae advances equitable and sustainable access to homeownership and quality, affordable rental housing for millions of people across America. We enable the 30-year fixed-rate mortgage and drive responsible innovation to make homebuying and renting easier, fairer, and more accessible. To learn more, visit: fanniemae.com | X (formerly Twitter) | Facebook | LinkedIn | Instagram | YouTube | Blog
Fannie Mae Newsroom
https://www.fanniemae.com/news
Photo of Fannie Mae
https://www.fanniemae.com/resources/img/about-fm/fm-building.tif
Fannie Mae Resource Center
1-800-2FANNIE
View original content to download multimedia:https://www.prnewswire.com/news-releases/fannie-mae-reports-net-income-of-17-0-billion-for-2024-and-4-1-billion-for-fourth-quarter-2024--302377029.html
SOURCE Fannie Mae
PR Newswire's news distribution, targeting, monitoring and marketing solutions help you connect and engage with target audiences across the globe.
- ROSEN, A LEADING LAW FIRM, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EPIX
- ROSEN, A LEADING LAW FIRM, Encourages BioAge Labs, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BIOA
- New Data Demonstrated Best-in-Class Potential for Casdatifan, a HIF-2a Inhibitor, in Patients with Metastatic Kidney Cancer
- CRBU Deadline: Rosen Law Firm Urges Caribou Biosciences, Inc. (NASDAQ: CRBU) Investors to Contact the Firm for Information About Their Rights
- TMDX Investors Have Opportunity to Lead TransMedics Group, Inc. Securities Fraud Lawsuit with the Schall Law Firm
- APLT Deadline: Rosen Law Firm Urges Applied Therapeutics, Inc. (NASDAQ: APLT) Investors to Contact the Firm for Information About Their Rights
